<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font16">for </span>
   <span class="font14">[]. </span>
   <span class="font14">with </span>
   <span class="font14">SARS-CoV- </span>
   <span class="font13">that </span>
   <span class="font12">The </span>
   <span class="font12">treatment </span>
   <span class="font12">was </span>
   <span class="font12">against </span>
   <span class="font12">[], </span>
   <span class="font12">clinical </span>
   <span class="font12">are </span>
   <span class="font11">COVID- </span>
   <span class="font11">have </span>
   <span class="font11">virus </span>
   <span class="font11">also </span>
   <span class="font11">coronavirus </span>
   <span class="font11">its </span>
   <span class="font11">antiviral </span>
   <span class="font11">been </span>
   <span class="font11">viral </span>
   <span class="font11">entry </span>
   <span class="font11">spike </span>
   <span class="font11">RNA </span>
   <span class="font11">respiratory </span>
   <span class="font11">has </span>
   <span class="font11">COVID-. </span>
   <span class="font11">Fig. </span>
   <span class="font11">RdRp </span>
   <span class="font11">patients </span>
   <span class="font11">protease </span>
   <span class="font11">protein </span>
   <span class="font11">shown </span>
   <span class="font11">drug </span>
   <span class="font11">from </span>
   <span class="font11">inhibitor </span>
   <span class="font11">{background </span>
   <span class="font11">like </span>
   <span class="font10">were </span>
   <span class="font10">inhibit </span>
   <span class="font10">proteins </span>
   <span class="font10">replication </span>
   <span class="font10">reported </span>
   <span class="font10">Mpro </span>
   <span class="font10">fusion </span>
   <span class="font10">inhibitors </span>
   <span class="font10">potential </span>
   <span class="font10">al. </span>
   <span class="font10">compound </span>
   <span class="font10">into </span>
   <span class="font10">studies </span>
   <span class="font10">syndrome </span>
   <span class="font10">which </span>
   <span class="font10">infection </span>
   <span class="font10">novel </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">activity </span>
   <span class="font10">cell </span>
   <span class="font10">margin </span>
   <span class="font10">their </span>
   <span class="font10">(Fig. </span>
   <span class="font10">However, </span>
   <span class="font10">SARS </span>
   <span class="font10">drugs </span>
   <span class="font10">human </span>
   <span class="font10">receptor </span>
   <span class="font10">severe </span>
   <span class="font10">target </span>
   <span class="font10">trial </span>
   <span class="font10">{border-style </span>
   <span class="font10">(accessed </span>
   <span class="font10">ACE- </span>
   <span class="font10">cells </span>
   <span class="font10">chloroquine </span>
   <span class="font10">effects </span>
   <span class="font10">host </span>
   <span class="font10">site </span>
   <span class="font10">(NCT) </span>
   <span class="font10">cathepsin </span>
   <span class="font10">px;} </span>
   <span class="font10">therapeutic </span>
   <span class="font10">trials </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">Wang, </span>
   <span class="font10">found </span>
   <span class="font10">further </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">potent </span>
   <span class="font10">targeting </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">binding </span>
   <span class="font10">domain </span>
   <span class="font10">remdesivir </span>
   <span class="font10">June </span>
   <span class="font10">Phase </span>
   <span class="font10">active </span>
   <span class="font10">associated </span>
   <span class="font10">being </span>
   <span class="font10">can </span>
   <span class="font10">discovery </span>
   <span class="font10">these </span>
   <span class="font10">(n.d.). </span>
   <span class="font10">Angiotensin </span>
   <span class="font10">Zhang, </span>
   <span class="font10">acute </span>
   <span class="font10">combination </span>
   <span class="font10">efficacy </span>
   <span class="font10">inhibits </span>
   <span class="font10">this </span>
   <span class="font10">use </span>
   <span class="font10">EKC </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Recently, </span>
   <span class="font10">new </span>
   <span class="font10">other </span>
   <span class="font10">study </span>
   <span class="font10">vitro </span>
   <span class="font10">â€" </span>
   <span class="font10">Structure </span>
   <span class="font10">compounds </span>
   <span class="font10">identified </span>
   <span class="font10">known </span>
   <span class="font10">potently </span>
   <span class="font10">two </span>
   <span class="font10">used </span>
   <span class="font10">well </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Chinese </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Liu, </span>
   <span class="font10">activation </span>
   <span class="font10">approach </span>
   <span class="font10">between </span>
   <span class="font10">development </span>
   <span class="font10">interaction </span>
   <span class="font10">protein, </span>
   <span class="font10">safety </span>
   <span class="font10">viruses </span>
   <span class="font10">â€". </span>
   <span class="font10">Li, </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">based </span>
   <span class="font10">bind </span>
   <span class="font10">effective </span>
   <span class="font10">enzyme </span>
   <span class="font10">enzymes </span>
   <span class="font10">injection, </span>
   <span class="font10">not </span>
   <span class="font10">polymerase </span>
   <span class="font10">residues </span>
   <span class="font10">results </span>
   <span class="font10">targets </span>
   <span class="font10">under </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Med. </span>
   <span class="font10">PLpro </span>
   <span class="font10">PubChem, </span>
   <span class="font10">action </span>
   <span class="font10">adverse </span>
   <span class="font10">both </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">cellular </span>
   <span class="font10">currently </span>
   <span class="font10">demonstrated </span>
   <span class="font10">due </span>
   <span class="font10">essential </span>
   <span class="font10">immune </span>
   <span class="font10">infections </span>
   <span class="font10">may </span>
   <span class="font10">molecular </span>
   <span class="font10">than </span>
   <span class="font10">through </span>
   <span class="font10">treating </span>
   <span class="font10">-nCoV </span>
   <span class="font10">East </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Infect. </span>
   <span class="font10">Middle </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">TCM </span>
   <span class="font10">about </span>
   <span class="font10">agents </span>
   <span class="font10">any </span>
   <span class="font10">approved </span>
   <span class="font10">blocking </span>
   <span class="font10">could </span>
   <span class="font10">furin </span>
   <span class="font10">genome </span>
   <span class="font10">high </span>
   <span class="font10">inhibition </span>
   <span class="font10">management </span>
   <span class="font10">medicine </span>
   <span class="font10">model </span>
   <span class="font10">natural </span>
   <span class="font10">priming </span>
   <span class="font10">px; </span>
   <span class="font10">screening </span>
   <span class="font10">such </span>
   <span class="font10">values </span>
   <span class="font10">{font-family </span>
   <span class="font10">ÂµM) </span>
   <span class="font10">(). </span>
   <span class="font10">(ECÂ </span>
   <span class="font10">.... </span>
   <span class="font10">Biol. </span>
   <span class="font10">CHNO </span>
   <span class="font10">CHOLESTEROL </span>
   <span class="font10">Ebola </span>
   <span class="font10">Vero </span>
   <span class="font10">after </span>
   <span class="font10">azithromycin </span>
   <span class="font10">complex </span>
   <span class="font10">conducted </span>
   <span class="font10">current </span>
   <span class="font10">designed </span>
   <span class="font10">disease </span>
   <span class="font10">doi:./.... </span>
   <span class="font10">effectively </span>
   <span class="font10">evaluate </span>
   <span class="font10">exhibited </span>
   <span class="font10">font-size </span>
   <span class="font10">glycyrrhizin </span>
   <span class="font10">highly </span>
   <span class="font10">increased </span>
   <span class="font10">lead </span>
   <span class="font10">membrane </span>
   <span class="font10">modeling </span>
   <span class="font10">pandemic </span>
   <span class="font10">process </span>
   <span class="font10">promising </span>
   <span class="font10">review </span>
   <span class="font10">ribavirin </span>
   <span class="font10">role </span>
   <span class="font10">sequence </span>
   <span class="font10">serine </span>
   <span class="font10">structure </span>
   <span class="font10">using </span>
   <span class="font10">virus, </span>
   <span class="font10">while </span>
   <span class="font10">(ICÂ </span>
   <span class="font10">Antiprotozoal </span>
   <span class="font10">BioRxiv. </span>
   <span class="font10">CoV- </span>
   <span class="font10">Drug </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Lopinavir </span>
   <span class="font10">Nafamostat </span>
   <span class="font10">Novel </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Treatment </span>
   <span class="font10">acid </span>
   <span class="font10">agent </span>
   <span class="font10">along </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">crucial </span>
   <span class="font10">docking </span>
   <span class="font10">double; </span>
   <span class="font10">form </span>
   <span class="font10">group </span>
   <span class="font10">hence </span>
   <span class="font10">include </span>
   <span class="font10">infected </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">inhibitors. </span>
   <span class="font10">interferon </span>
   <span class="font10">ivermectin </span>
   <span class="font10">levels </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">main </span>
   <span class="font10">major </span>
   <span class="font10">mediated </span>
   <span class="font10">molecules </span>
   <span class="font10">papain-like </span>
   <span class="font10">peptides </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">prevention </span>
   <span class="font10">proteases </span>
   <span class="font10">recent </span>
   <span class="font10">receptors </span>
   <span class="font10">replicase </span>
   <span class="font10">required </span>
   <span class="font10">respectively </span>
   <span class="font10">revealed </span>
   <span class="font10">rhesus </span>
   <span class="font10">strategy </span>
   <span class="font10">therapy </span>
   <span class="font10">underway </span>
   <span class="font10">via </span>
   <span class="font10">virus. </span>
   <span class="font10">(ACE-) </span>
   <span class="font10">Acad. </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Clinical </span>
   <span class="font10">Currently, </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Furin </span>
   <span class="font10">HCV </span>
   <span class="font10">RBD </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">Res../j.antiviral... </span>
   <span class="font10">Sci. </span>
   <span class="font10">Table </span>
   <span class="font10">These </span>
   <span class="font10">This </span>
   <span class="font10">Transmembrane </span>
   <span class="font10">Zhou, </span>
   <span class="font10">amino </span>
   <span class="font10">atazanavir </span>
   <span class="font10">attachment </span>
   <span class="font10">available </span>
   <span class="font10">belonging </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">camostat </span>
   <span class="font10">candidates </span>
   <span class="font10">compared </span>
   <span class="font10">control </span>
   <span class="font10">converting </span>
   <span class="font10">dependent </span>
   <span class="font10">design </span>
   <span class="font10">developed </span>
   <span class="font10">epithelial </span>
   <span class="font10">evidence </span>
   <span class="font10">exhibit </span>
   <span class="font10">hepatitis </span>
   <span class="font10">highlighted </span>
   <span class="font10">homology </span>
   <span class="font10">hospitalized </span>
   <span class="font10">importance </span>
   <span class="font10">includes </span>
   <span class="font10">information </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibitory </span>
   <span class="font10">leads </span>
   <span class="font10">might </span>
   <span class="font10">molecule </span>
   <span class="font10">non-structural </span>
   <span class="font10">nsp </span>
   <span class="font10">polyprotein </span>
   <span class="font10">possess </span>
   <span class="font10">possible </span>
   <span class="font10">presence </span>
   <span class="font10">prevent </span>
   <span class="font10">previously </span>
   <span class="font10">protection </span>
   <span class="font10">proteolytic </span>
   <span class="font10">prove </span>
   <span class="font10">receptor, </span>
   <span class="font10">repurposed </span>
   <span class="font10">response </span>
   <span class="font10">resulting </span>
   <span class="font10">several </span>
   <span class="font10">showed </span>
   <span class="font10">significant </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">ÂµM, </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">(TMPRSS) </span>
   <span class="font10">-Chymotrypsin </span>
   <span class="font10">-fold </span>
   <span class="font10">Azithromycin </span>
   <span class="font10">CLpro </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Camara, </span>
   <span class="font10">Carrimycin </span>
   <span class="font10">Chen, </span>
   <span class="font10">China </span>
   <span class="font10">Fusion </span>
   <span class="font10">GS- </span>
   <span class="font10">Gilead </span>
   <span class="font10">Hence, </span>
   <span class="font10">Hu, </span>
   <span class="font10">IL- </span>
   <span class="font10">Infectious </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">JAK </span>
   <span class="font10">MERS </span>
   <span class="font10">Medicine </span>
   <span class="font10">Mol. </span>
   <span class="font10">Mpro. </span>
   <span class="font10">Natl. </span>
   <span class="font10">Pneumonia </span>
   <span class="font10">Polymerase </span>
   <span class="font10">Res. </span>
   <span class="font10">Res../j.antiviral.. </span>
   <span class="font10">Rev. </span>
   <span class="font10">Science </span>
   <span class="font10">Since </span>
   <span class="font10">Spike </span>
   <span class="font10">Teicoplanin </span>
   <span class="font10">Traditional </span>
   <span class="font10">Xu, </span>
   <span class="font10">Yang, </span>
   <span class="font10">act </span>
   <span class="font10">affinity </span>
   <span class="font10">analysis </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">approaches </span>
   <span class="font10">atazanavir/ritonavir </span>
   <span class="font10">bacterial </span>
   <span class="font10">bold </span>
   <span class="font10">cell. </span>
   <span class="font10">centre </span>
   <span class="font10">cleavage </span>
   <span class="font10">clinically </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">courier; </span>
   <span class="font10">crystal </span>
   <span class="font10">cytokine </span>
   <span class="font10">data </span>
   <span class="font10">derivatives </span>
   <span class="font10">diagram </span>
   <span class="font10">different </span>
   <span class="font10">druggable </span>
   <span class="font10">east </span>
   <span class="font10">effectiveness </span>
   <span class="font10">em; </span>
   <span class="font10">enzyme- </span>
   <span class="font10">established </span>
   <span class="font10">evaluated </span>
   <span class="font10">existing </span>
   <span class="font10">explored </span>
   <span class="font10">favipiravir </span>
   <span class="font10">functions </span>
   <span class="font10">global </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">higher </span>
   <span class="font10">hostâ€™s </span>
   <span class="font10">inflammatory </span>
   <span class="font10">inhibited </span>
   <span class="font10">inside </span>
   <span class="font10">interferes </span>
   <span class="font10">intervention </span>
   <span class="font10">large </span>
   <span class="font10">lopinavir </span>
   <span class="font10">low </span>
   <span class="font10">making </span>
   <span class="font10">metabolic </span>
   <span class="font10">middle </span>
   <span class="font10">more </span>
   <span class="font10">nafamostat </span>
   <span class="font10">needs </span>
   <span class="font10">nsp-, </span>
   <span class="font10">nsps </span>
   <span class="font10">nucleoside </span>
   <span class="font10">number </span>
   <span class="font10">one </span>
   <span class="font10">optimization </span>
   <span class="font10">patent </span>
   <span class="font10">pathogenic </span>
   <span class="font10">previous </span>
   <span class="font10">profile </span>
   <span class="font10">protease, </span>
   <span class="font10">proteins, </span>
   <span class="font10">proven </span>
   <span class="font10">pseudovirus </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently </span>
   <span class="font10">regarding </span>
   <span class="font10">repeat </span>
   <span class="font10">report </span>
   <span class="font10">research </span>
   <span class="font10">resource </span>
   <span class="font10">ribavirin, </span>
   <span class="font10">screened </span>
   <span class="font10">should </span>
   <span class="font10">similarity </span>
   <span class="font10">six </span>
   <span class="font10">small </span>
   <span class="font10">structural </span>
   <span class="font10">structures </span>
   <span class="font10">suggested </span>
   <span class="font10">symptoms </span>
   <span class="font10">synthesis </span>
   <span class="font10">system </span>
   <span class="font10">teicoplanin </span>
   <span class="font10">they </span>
   <span class="font10">three </span>
   <span class="font10">thus </span>
   <span class="font10">toxicity </span>
   <span class="font10">type </span>
   <span class="font10">understanding </span>
   <span class="font10">vaccines </span>
   <span class="font10">value </span>
   <span class="font10">virtual </span>
   <span class="font10">without </span>
   <span class="font10">would </span>
   <span class="font10">ÂµM </span>
   <span class="font10">ÂµM). </span>
  </p>
 </body>
</html>
